Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 Nov;38(11):2572–2576. doi: 10.1128/aac.38.11.2572

Guanylhydrazones in therapy of Pneumocystis carinii pneumonia in immunosuppressed rats.

P D Walzer 1, J Foy 1, J Runck 1, P Steele 1, M White 1, R S Klein 1, B A Otter 1, R J Sundberg 1
PMCID: PMC188244  PMID: 7872750

Abstract

Guanylhydrazones are cationic heteroaromatic drugs similar to the diamidines which are effective in the treatment of African trypanosomiasis and pneumocystosis. On the basis of their antitrypanosomal activity, different guanylhydrazones were selected for evaluation in a rat model of Pneumocystis carinii pneumonia. The most active compounds were the 2-(4'-formylphenyl)-1-methylimidazo-[1,2-a] pyridinium guanylhydrazones which, at a dose of 2 mg/kg/day, were about as effective as trimethoprim-sulfamethoxazole at a dose of 50 mg of trimethoprim per kg/day plus 250 mg of sulfamethoxazole per kg/day. The anti-P. carinii activity of these guanylhydrazone derivatives was found with parenteral but not with oral administration. The 1,3-arylene diketone bis(guanylhydrazones) were generally ineffective, although a triacetyl derivative showed some anti-P. carinii activity. Nitroimidazole guanylhydrazone derivatives were also ineffective. Attempts to improve the therapeutic efficacy of the different guanylhydrazones were limited by problems of toxicity. We conclude that some guanylhydrazone derivatives are potent anti-P. carinii drugs and that further studies should be pursued to develop safer compounds and investigate structure-activity relationships.

Full text

PDF
2572

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apted F. I. Present status of chemotherapy and chemopropylaxis of human trypanosomiasis in the Eastern Hemisphere. Pharmacol Ther. 1980;11(2):391–413. doi: 10.1016/0163-7258(80)90035-2. [DOI] [PubMed] [Google Scholar]
  2. Bitonti A. J., Dumont J. A., McCann P. P. Characterization of Trypanosoma brucei brucei S-adenosyl-L-methionine decarboxylase and its inhibition by Berenil, pentamidine and methylglyoxal bis(guanylhydrazone). Biochem J. 1986 Aug 1;237(3):685–689. doi: 10.1042/bj2370685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chang K. P., Steiger R. F., Dave C., Cheng Y. C. Effects of methylglyoxal bis(ganylhydrazone) on trypanosomatid flagellates: inhibition of growth and nucleoside incorporation in Trypanosoma brucei. J Protozool. 1978 Feb;25(1):145–149. doi: 10.1111/j.1550-7408.1978.tb03887.x. [DOI] [PubMed] [Google Scholar]
  4. Clarkson A. B., Jr, Sarić M., Grady R. W. Deferoxamine and eflornithine (DL-alpha-difluoromethylornithine) in a rat model of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother. 1990 Sep;34(9):1833–1835. doi: 10.1128/aac.34.9.1833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cory M., Tidwell R. R., Fairley T. A. Structure and DNA binding activity of analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) J Med Chem. 1992 Feb 7;35(3):431–438. doi: 10.1021/jm00081a003. [DOI] [PubMed] [Google Scholar]
  6. Douc-Rasy S., Kayser A., Riou J. F., Riou G. ATP-independent type II topoisomerase from trypanosomes. Proc Natl Acad Sci U S A. 1986 Oct;83(19):7152–7156. doi: 10.1073/pnas.83.19.7152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dykstra C. C., Tidwell R. R. Inhibition of topoisomerases from Pneumocystis carinii by aromatic dicationic molecules. J Protozool. 1991 Nov-Dec;38(6):78S–81S. [PubMed] [Google Scholar]
  8. Fairley T. A., Tidwell R. R., Donkor I., Naiman N. A., Ohemeng K. A., Lombardy R. J., Bentley J. A., Cory M. Structure, DNA minor groove binding, and base pair specificity of alkyl- and aryl-linked bis(amidinobenzimidazoles) and bis(amidinoindoles). J Med Chem. 1993 Jun 11;36(12):1746–1753. doi: 10.1021/jm00064a008. [DOI] [PubMed] [Google Scholar]
  9. Feigon J., Denny W. A., Leupin W., Kearns D. R. Interactions of antitumor drugs with natural DNA: 1H NMR study of binding mode and kinetics. J Med Chem. 1984 Apr;27(4):450–465. doi: 10.1021/jm00370a007. [DOI] [PubMed] [Google Scholar]
  10. Ferguson L. R., Sundberg R. J. Petite mutagenesis in Saccharomyces cerevisiae by a series of bis-cationic trypanocidal drugs. Antimicrob Agents Chemother. 1991 Nov;35(11):2318–2321. doi: 10.1128/aac.35.11.2318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Goldenberg D. M., Sharkey R. M., Udem S., Vagg R., Levine G. M., Conte P., Swayne L. C., Hansen H. J., Cunniff D., Anton J. Immunoscintigraphy of Pneumocystis carinii pneumonia in AIDS patients. J Nucl Med. 1994 Jun;35(6):1028–1034. [PubMed] [Google Scholar]
  12. Jennings F. W., Atouguia J. M., Murray M. Topical melarsoprol for trypanosomiasis. Lancet. 1993 May 22;341(8856):1341–1342. doi: 10.1016/0140-6736(93)90846-9. [DOI] [PubMed] [Google Scholar]
  13. Jones S. K., Hall J. E., Allen M. A., Morrison S. D., Ohemeng K. A., Reddy V. V., Geratz J. D., Tidwell R. R. Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia. Antimicrob Agents Chemother. 1990 Jun;34(6):1026–1030. doi: 10.1128/aac.34.6.1026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kim C. K., Foy J. M., Cushion M. T., Stanforth D., Linke M. J., Hendrix H. L., Walzer P. D. Comparison of histologic and quantitative techniques in evaluation of therapy for experimental Pneumocystis carinii pneumonia. Antimicrob Agents Chemother. 1987 Feb;31(2):197–201. doi: 10.1128/aac.31.2.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Luck G., Reinert K. E., Baguley B., Zimmer C. Interaction of the nonintercalative antitumour drugs SN-6999 and SN-18071 with DNA: influence of ligand structure on the binding specificity. J Biomol Struct Dyn. 1987 Jun;4(6):1079–1094. doi: 10.1080/07391102.1987.10507699. [DOI] [PubMed] [Google Scholar]
  16. Masur H. Prevention and treatment of pneumocystis pneumonia. N Engl J Med. 1992 Dec 24;327(26):1853–1860. doi: 10.1056/NEJM199212243272606. [DOI] [PubMed] [Google Scholar]
  17. Pearson R. D., Hewlett E. L. Pentamidine for the treatment of Pneumocystis carinii pneumonia and other protozoal diseases. Ann Intern Med. 1985 Nov;103(5):782–786. doi: 10.7326/0003-4819-103-5-782. [DOI] [PubMed] [Google Scholar]
  18. Pjura P. E., Grzeskowiak K., Dickerson R. E. Binding of Hoechst 33258 to the minor groove of B-DNA. J Mol Biol. 1987 Sep 20;197(2):257–271. doi: 10.1016/0022-2836(87)90123-9. [DOI] [PubMed] [Google Scholar]
  19. Ross W. J., Jamieson W. B. Antiparasitic nitroimidazoles. 8. Derivatives of 2-(4-formylstyryl)-5-nitro-1-vinylimidazole. J Med Chem. 1975 Feb;18(2):158–161. doi: 10.1021/jm00236a009. [DOI] [PubMed] [Google Scholar]
  20. Shapiro T. A., Englund P. T. Selective cleavage of kinetoplast DNA minicircles promoted by antitrypanosomal drugs. Proc Natl Acad Sci U S A. 1990 Feb;87(3):950–954. doi: 10.1073/pnas.87.3.950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Smith J. W., Bartlett M. S., Queener S. F., Durkin M. M., Jay M. A., Hull M. T., Klein R. S., Marr J. J. Pneumocystis carinii pneumonia therapy with 9-deazainosine in rats. Diagn Microbiol Infect Dis. 1987 Jun;7(2):113–118. doi: 10.1016/0732-8893(87)90028-9. [DOI] [PubMed] [Google Scholar]
  22. Sundberg R. J., Dahlhausen D. J., Manikumar G., Mavunkel B., Biswas A., Srinivasan V., Musallam H. A., Reid W. A., Jr, Ager A. L. Cationic antiprotozoal drugs. Trypanocidal activity of 2-(4'-formylphenyl)imidazo[1,2-a]pyridinium guanylhydrazones and related derivatives of quaternary heteroaromatic compounds. J Med Chem. 1990 Jan;33(1):298–307. doi: 10.1021/jm00163a049. [DOI] [PubMed] [Google Scholar]
  23. Tidwell R. R., Jones S. K., Geratz J. D., Ohemeng K. A., Cory M., Hall J. E. Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia. J Med Chem. 1990 Apr;33(4):1252–1257. doi: 10.1021/jm00166a026. [DOI] [PubMed] [Google Scholar]
  24. Tidwell R. R., Jones S. K., Naiman N. A., Berger L. C., Brake W. B., Dykstra C. C., Hall J. E. Activity of cationically substituted bis-benzimidazoles against experimental Pneumocystis carinii pneumonia. Antimicrob Agents Chemother. 1993 Aug;37(8):1713–1716. doi: 10.1128/aac.37.8.1713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ulrich P., Cerami A. Trypanocidal 1,3-arylene diketone bis(guanylhydrazone)s. Structure-activity relationships among substituted and heterocyclic analogues. J Med Chem. 1984 Jan;27(1):35–40. doi: 10.1021/jm00367a007. [DOI] [PubMed] [Google Scholar]
  26. Walzer P. D., Foy J., Steele P., White M. Synergistic combinations of Ro 11-8958 and other dihydrofolate reductase inhibitors with sulfamethoxazole and dapsone for therapy of experimental pneumocystosis. Antimicrob Agents Chemother. 1993 Jul;37(7):1436–1443. doi: 10.1128/aac.37.7.1436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Walzer P. D., Foy J., Steele P., White M. Treatment of experimental pneumocystosis: review of 7 years of experience and development of a new system for classifying antimicrobial drugs. Antimicrob Agents Chemother. 1992 Sep;36(9):1943–1950. doi: 10.1128/aac.36.9.1943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Walzer P. D., Kim C. K., Foy J., Linke M. J., Cushion M. T. Cationic antitrypanosomal and other antimicrobial agents in the therapy of experimental Pneumocystis carinii pneumonia. Antimicrob Agents Chemother. 1988 Jun;32(6):896–905. doi: 10.1128/aac.32.6.896. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES